Tratnjek L et al.Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation.Eur J Neurosci 43:885-98 (2016).
Arosh JA et al.Molecular and preclinical basis to inhibit PGE2 receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis.Proc Natl Acad Sci U S A 112:9716-21 (2015).
Wang H et al.Increasing expression of substance P and calcitonin gene-related peptide in synovial tissue and fluid contribute to the progress of arthritis in developmental dysplasia of the hip.Arthritis Res Ther 17:4 (2015).
Wang H et al.Increasing substance P levels in serum and synovial tissues from patients with developmental dysplasia of the hip (DDH).BMC Musculoskelet Disord 15:92 (2014).
Colas D et al.Orexin A and orexin receptor 1 axonal traffic in dorsal roots at the CNS/PNS interface.Front Neurosci 8:20 (2014).
Maguma HT et al.Specific localization of ß-Arrestin2 in myenteric plexus of mouse gastrointestinal tract.PLoS One 9:e103894 (2014).
IHC (PFA fixed)
Murphy SR et al.Ozone-induced airway epithelial cell death, the neurokinin-1 receptor pathway, and the postnatal developing lung.Am J Physiol Lung Cell Mol Physiol 307:L471-81 (2014).
Mijouin L et al.Effects of a skin neuropeptide (substance p) on cutaneous microflora.PLoS One 8:e78773 (2013).
Meng J et al.Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.J Cell Sci 120:2864-74 (2007).